TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC.

Luise KlapperChristian IdelPatrick KupplerTobias JagomastAmelie von BernuthKarl-Ludwig BruchhageDirk RadesAnne OffermannJutta KirfelSven PernerChristian Idel

Published in: Journal of personalized medicine (2022)

TRIM24 might be a new prognostic biomarker for the survival prognosis and early detection of local recurrences in HNSCC patients. It could be used for risk stratification of HNSCC patients and to identify those patients who are more prone to develop a local recurrence and therefore could profit from more frequent follow-up examinations.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
free survival
binding protein